Cameron R. Nelson
Finanzdirektor/CFO bei Mati Therapeutics, Inc.
Profil
Cameron R.
Nelson is currently the Chief Financial Officer at Mati Therapeutics, Inc. Previously, he worked as the Chief Financial Officer & Senior Vice President at QLT, Inc. from 2011 to 2012.
Mr. Nelson holds an MBA from Dartmouth College and an undergraduate degree from the University of British Columbia.
Aktive Positionen von Cameron R. Nelson
| Unternehmen | Position | Beginn |
|---|---|---|
Mati Therapeutics, Inc.
 Mati Therapeutics, Inc. BiotechnologyHealth Technology Mati Therapeutics, Inc. operates as biotechnology company. It develops non-invasive sustained drug delivery platform to treat ocular diseases, in particular glaucoma. The company was founded by Robert Lee Butchofsky and Christopher A. Muller and is headquartered in Austin, TX. | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von Cameron R. Nelson
| Unternehmen | Position | Ende |
|---|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Finanzdirektor/CFO | 09.07.2012 |
Ausbildung von Cameron R. Nelson
| Dartmouth College | Masters Business Admin |
| University of British Columbia | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Mati Therapeutics, Inc.
Mati Therapeutics, Inc. BiotechnologyHealth Technology Mati Therapeutics, Inc. operates as biotechnology company. It develops non-invasive sustained drug delivery platform to treat ocular diseases, in particular glaucoma. The company was founded by Robert Lee Butchofsky and Christopher A. Muller and is headquartered in Austin, TX. | Health Technology |
